The trademark application SHEPNUVI was filed by PTC Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 6, 2023, and it was registered by office on May 16, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1731201 at the World Intellectual Property Organization (WIPO).
The application was filed in Dutch (English was selected as the second language).
Change of name and address of the trademark registration was recorded on June 13, 2024.